Prestige Wealth Management Group LLC Abbott Laboratories Transaction History

Prestige Wealth Management Group LLC

$442 Million
Q2 2024

A detailed history of Prestige Wealth Management Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 3,809 shares of ABT stock, worth $427,522. This represents 0.09% of its overall portfolio holdings.

Number of Shares

3,809

Previous 3,834 0.65%

Holding current value

$427,522

Previous $435,000 9.2%

% of portfolio

0.09%

Previous 0.1%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$100.73 - $112.44 $2,518 - $2,811	-25 Reduced 0.65%	3,809 $395,000
Q1 2024 Apr 26, 2024	BUY	$109.52 - $120.96 $766 - $846	7 Added 0.18%	3,834 $435,000
Q4 2023 Apr 26, 2024	SELL	$90.19 - $110.4 $47,439 - $58,070	-526 Reduced 12.08%	3,827 $421,000
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $47,439 - $58,070	-526 Reduced 12.08%	3,827 $421,000
Q3 2023 Apr 26, 2024	SELL	$95.53 - $114.62 $1,050 - $1,260	-11 Reduced 0.25%	4,353 $421,000
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $1,050 - $1,260	-11 Reduced 0.25%	4,353 $421,000
Q2 2023 Apr 26, 2024	SELL	$100.78 - $112.29 $501,380 - $558,642	-4,975 Reduced 53.27%	4,364 $475,000
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $501,380 - $558,642	-4,975 Reduced 53.27%	4,364 $475,000
Q1 2023 Apr 26, 2024	BUY	$96.86 - $114.01 $533,214 - $627,625	5,505 Added 143.58%	9,339 $945,000
Q1 2023 May 16, 2023	BUY	$96.86 - $114.01 $494,470 - $582,021	5,105 Added 120.57%	9,339 $945,000
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $408,758 - $479,536	-4,300 Reduced 50.39%	4,234 $464,000
Q3 2022 Nov 01, 2022	BUY	$96.76 - $112.03 $69,570 - $80,549	719 Added 9.2%	8,534 $825,000
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $26,742 - $32,322	262 Added 3.47%	7,815 $849,000
Q1 2022 May 05, 2022	BUY	$114.02 - $139.04 $471,130 - $574,513	4,132 Added 120.78%	7,553 $894,000
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $13,748 - $16,833	119 Added 3.6%	3,421 $482,000
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $32,198 - $35,620	276 Added 9.12%	3,302 $390,000
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $47,922 - $56,412	-453 Reduced 13.02%	3,026 $351,000
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $31,672 - $37,314	291 Added 9.13%	3,479 $417,000
Q4 2020 Feb 17, 2021	BUY	$105.0 - $114.42 $31,080 - $33,868	296 Added 10.24%	3,188 $349,000
Q3 2020 Oct 26, 2020	BUY	$91.64 - $111.29 $55,075 - $66,885	601 Added 26.23%	2,892 $315,000
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $117,917 - $150,920	1,540 Added 205.06%	2,291 $209,000
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $29,211 - $42,714	465 Added 162.59%	751 $59,000
Q4 2019 Jan 28, 2020	SELL	$78.51 - $87.4 $471 - $524	-6 Reduced 2.05%	286 $25,000
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $491 - $532	6 Added 2.1%	292 $24,000
Q1 2019 Aug 16, 2019	SELL	$66.22 - $80.06 $23,905 - $28,901	-361 Reduced 55.8%	286 $23,000
Q4 2018 Apr 16, 2019	BUY	$65.56 - $74.27 $42,417 - $48,052	647 New	647 $47,000

Others Institutions Holding ABT

# of Institutions

3,136

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.

Account

Prestige Wealth Management Group LLC Abbott Laboratories Transaction History